| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Gross margin | 49,0 k € | -23.3% | 63,9 k € | +22.3% | 52,2 k € | +1.4% | 51,5 k € | +11.3% | 46,3 k € | -4.0% | 48,2 k € | |
| EBITDA | 47,8 k € | -23.7% | 62,7 k € | +24.4% | 50,4 k € | +4.3% | 48,3 k € | +10.8% | 43,6 k € | -5.5% | 46,2 k € | |
| Operating profit | 42,8 k € | -10.8% | 48,0 k € | +42.8% | 33,6 k € | -17.4% | 40,7 k € | +2.7% | 39,6 k € | -14.0% | 46,0 k € | |
| Profit/loss | 156,0 k € | +335.9% | 35,8 k € | +48.3% | 24,1 k € | -26.2% | 32,7 k € | +2.7% | 31,9 k € | -18.0% | 38,8 k € | |
| Equity | 34,6 k € | +86.2% | 18,6 k € | 0.0% | 18,6 k € | 0.0% | 18,6 k € | -83.5% | 112,4 k € | +51.2% | 74,4 k € | |
| Total assets | 155,7 k € | +76.1% | 88,4 k € | +5.2% | 84,0 k € | -24.1% | 110,7 k € | -24.1% | 145,8 k € | +44.3% | 101,0 k € | |
| Cash | 104,1 k € | +1728.6% | 5,7 k € | +1308.5% | 404,0 € | +5.5% | 383,1 € | -98.5% | 24,9 k € | +1374.3% | 1,7 k € | |
| Debts | 121,0 k € | +73.4% | 69,8 k € | +6.7% | 65,4 k € | -28.9% | 92,1 k € | +176.4% | 33,3 k € | +25.1% | 26,6 k € | |
Private limited company · Tournai · incorporated on 24/01/2019
Private limited company profitable but thinly capitalised. Cash position rising (+1728.6%).
Acceptable counterparty for a moderate engagement. Require 2 fiscal years of detailed accounts before any significant exposure — thin equity (34,6 k €) relative to earnings. The abridged model hides revenue.
PHARMA BIO CONSULT is a Private limited company incorporated in 2019. Its main activity is: Technical testing and analysis. Its registered office is in Tournai.
Key indicators
7-day free trial, no credit card required.
7-day free trial, no credit card required.
7-day free trial, no credit card required.
Source: Belgian Official Gazette